Following concerning reports from Japan about health supplements associated with several deaths and numerous hospitalizations, Singapore’s Health Sciences Authority (HSA) has reassured the public that the implicated products are not available in the local market.
Alarming Reports from Japan
Japan recently witnessed a troubling scenario where five individuals lost their lives, and more than a hundred were hospitalized after consuming health supplements containing red yeast rice. These products, purported to aid in reducing cholesterol levels, raised significant health concerns due to the presence of unintended ingredients suspected to cause kidney problems among users.
HSA’s Proactive Response
In response to these incidents, HSA promptly investigated the availability of these supplements in Singapore. The authority confirmed that the specific products linked to the adverse health events in Japan have not been marketed in Singapore. This announcement comes as a relief to consumers concerned about the safety of similar health supplements available locally.
Ongoing Vigilance
HSA continues to monitor the situation closely and remains committed to safeguarding public health by ensuring that all health products available in Singapore meet stringent safety standards. Consumers are encouraged to remain informed and cautious about their health supplement choices, seeking professional advice when in doubt.
Also learn about Sake Products Withdrawn in Singapore Over Health Concerns.
